WPI 2286 Pill: white, capsule/oblong, 23mm
The pill with imprint WPI 2286 (White, Capsule/Oblong, 23mm) has been identified as Propafenone Hydrochloride Extended-Release 325 mg and is used for Atrial Fibrillation, Wolff-Parkinson-White Syndrome, Ventricular Tachycardia, and Atrial Flutter. It belongs to the drug class group I antiarrhythmics and is not a controlled substance.
Images for WPI 2286
Propafenone Hydrochloride Extended-Release
- Imprint
- WPI 2286
- Strength
- 325 mg
- Color
- White
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-2286
- Inactive Ingredients
-
ferrosoferric oxide,
gelatin,
hypromelloses,
magnesium stearate,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
See also:
More about propafenone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.